Noel Rock (Dublin North West, Fine Gael)
Link to this: Individually | In context | Oireachtas source

1013. To ask the Minister for Health the current position regarding the shortage of the BCG tuberculosis vaccine; and if he will make a statement on the matter. [24410/16]

Séamus Healy (Tipperary, Workers and Unemployed Action Group)
Link to this: Individually | In context | Oireachtas source

1403. To ask the Minister for Health the position regarding the shortage of the BCG vaccine here; and if he will make a statement on the matter. [25963/16]

Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source

I propose to take Questions Nos. 1013 and 1403 together.

There is currently a worldwide shortage of BCG vaccine.  In 2015 the United Nations Children's Funds (UNICEF) estimated a worldwide shortage of 65 million doses of BCG. The vaccine has not been available in Ireland since the end of April 2015. The manufacturer has had difficulties in the production of the BCG vaccine. The manufacturer has informed the HSE there will be no supply of BCG until 2017. Consequently, BCG vaccination clinics in HSE Clinics and Maternity hospitals have been postponed until new stock arrives.

There is only one licensed supplier of BCG vaccine to Ireland and to other countries within the EU. Since this problem became apparent, the HSE National Immunisation Office has been in regular contact with the manufacturer of BCG vaccine to ascertain when the vaccine might be available. The HSE has also asked the Health Products Regulatory Authority (HPRA), which licenses and regulates all human medicines in Ireland, to source an alternate supplier of the BCG vaccine. Efforts have been made to find a company who can provide the vaccine for use in Ireland which satisfies all the HPRA requirements on safety and efficacy. To date no suitable alternative BCG product has been found. Therefore the HSE has been unable to procure the BCG vaccine from any other source and still awaits the product from the HPRA licensed supplier of the vaccine.

The supplier has indicated that supplies of the vaccine are not expected to be delivered into Ireland until early 2017. When there is confirmation of the date of new supply a decision will be made, guided by the recommendations of the National Immunisation Advisory Committee, on who should be prioritised to receive the vaccine.

In Ireland the number of cases of tuberculosis (TB)has been falling. TB is a notifiable disease under the Infectious Diseases (Amendment) Regulations 2016 (S.I. No. 276 of 2016). In 2015, 318 cases of TB were notified to the Health Protection Surveillance Centre, giving a national TB notification rate of 6.9 per 100,000, the lowest rate reported since surveillance commenced. According to the World Health Organisation, the definition of a low incidence TB country is one with a national TB notification rate of less than 10 cases per 100,000, Ireland is in this category. The risk to babies remains unchanged, even allowing for delay in getting BCG vaccine in Ireland.